Log in to your Inderes Free account to see all free content on this page.
Clinical Laserthermia Systems
7.60 SEK
+2.98 %
Less than 1K followers
CLS B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.98 %
-12.84 %
-35.70 %
+161.62 %
+107.65 %
+79.25 %
-85.01 %
-97.20 %
-96.92 %
Clinical Laserthermia Systems operates in the medical technology sector. The company's vision is to develop and streamline the treatment of solid cancer tumors, where the company is a seller of sterile patient kits. The products are used in various cancer treatments such as in the treatment of malignant melanoma, as well as cancer of the lungs, liver and pancreas. The company was founded in 2006 and has its headquarters in Lund.
Read moreMarket cap
236.87M SEK
Turnover
324.39K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.2.
2026
Annual report '25
15.5.
2026
Interim report Q1'26
14.8.
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
Redeye: CLS Q3 (Review) - Soft sales, but better quarters ahead
CLS Publishes Interim Report January - September 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio